These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20601278)

  • 1. Small molecules from natural sources, targeting signaling pathways in diabetes.
    Liu Q; Chen L; Hu L; Guo Y; Shen X
    Biochim Biophys Acta; 2010; 1799(10-12):854-65. PubMed ID: 20601278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for the development of new PPAR agonists in diabetes.
    Cavender MA; Nicholls SJ; Lincoff AM
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S32-7. PubMed ID: 20489419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Alkaloids Intervening the Insulin Pathway: New Hopes for Anti-Diabetic Agents?
    Christodoulou MI; Tchoumtchoua J; Skaltsounis AL; Scorilas A; Halabalaki M
    Curr Med Chem; 2019; 26(32):5982-6015. PubMed ID: 29714135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plants Secondary Metabolites as Blood Glucose-Lowering Molecules.
    Shehadeh MB; Suaifan GARY; Abu-Odeh AM
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review on Molecular Mechanism of Flavonoids as Antidiabetic Agents.
    Jasmin ; Jaitak V
    Mini Rev Med Chem; 2019; 19(9):762-786. PubMed ID: 30588881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety issues and prospects for future generations of PPAR modulators.
    Rubenstrunk A; Hanf R; Hum DW; Fruchart JC; Staels B
    Biochim Biophys Acta; 2007 Aug; 1771(8):1065-81. PubMed ID: 17428730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-diabetic compounds and their patent information: an update.
    Pandey R; Kumar N; Yadav M; Nagpal R; Jain S; Yadav H
    Recent Pat Inflamm Allergy Drug Discov; 2013 Jan; 7(1):35-48. PubMed ID: 23016523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of natural compounds on insulin signaling.
    Paoli P; Caselli A; Camici G; Cirri P
    Curr Med Chem; 2015; 22(1):80-111. PubMed ID: 25139055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-diabetic polysaccharides from natural sources: A review.
    Wang PC; Zhao S; Yang BY; Wang QH; Kuang HX
    Carbohydr Polym; 2016 Sep; 148():86-97. PubMed ID: 27185119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids.
    Kawser Hossain M; Abdal Dayem A; Han J; Yin Y; Kim K; Kumar Saha S; Yang GM; Choi HY; Cho SG
    Int J Mol Sci; 2016 Apr; 17(4):569. PubMed ID: 27092490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chalcones and their therapeutic targets for the management of diabetes: structural and pharmacological perspectives.
    Mahapatra DK; Asati V; Bharti SK
    Eur J Med Chem; 2015 Mar; 92():839-65. PubMed ID: 25638569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyphenols: Potential Future Arsenals in the Treatment of Diabetes.
    Solayman M; Ali Y; Alam F; Islam MA; Alam N; Khalil MI; Gan SH
    Curr Pharm Des; 2016; 22(5):549-65. PubMed ID: 26601968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
    Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
    Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.
    Cheang WS; Tian XY; Wong WT; Lau CW; Lee SS; Chen ZY; Yao X; Wang N; Huang Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):830-6. PubMed ID: 24482374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma-ligand, in insulin-deficient diabetic rats.
    Yamagishi S; Ogasawara S; Mizukami H; Yajima N; Wada R; Sugawara A; Yagihashi S
    J Neurochem; 2008 Jan; 104(2):491-9. PubMed ID: 17995925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal mushrooms for glycemic control in diabetes mellitus: history, current status, future perspectives, and unsolved problems (review).
    Lo HC; Wasser SP
    Int J Med Mushrooms; 2011; 13(5):401-26. PubMed ID: 22324407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulino-mimetic and anti-diabetic effects of zinc.
    Vardatsikos G; Pandey NR; Srivastava AK
    J Inorg Biochem; 2013 Mar; 120():8-17. PubMed ID: 23266931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy as a target for development of anti-diabetes drugs derived from natural compounds.
    Zhang XW; Zhou JC; Hu ZW
    J Asian Nat Prod Res; 2017 Apr; 19(4):314-319. PubMed ID: 28347174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.